M. Abe, Y. Orita, Y. Nakashima, and M. Nakamura, , 1984.

, Hypertensive crisis induced by metoclopramide in patient with pheochromocytoma, Angiology, vol.35, pp.122-128

E. Adler-graschinsky, M. Rubio, and M. Moyano, Metoclopramide Increases the Release of Catecholamines from Isolated Human Phaeochromocytomas, Journal of Hypertension, vol.2, issue.2, pp.127-129, 1984.
DOI : 10.1097/00004872-198404000-00002

E. Agabiti-rosei, C. Alicandria, and . Corea, HYPERTENSIVE CRISIS IN PATIENTS WITH PHAEOCHROMOCYTOMA GIVEN METOCLOPRAMIDE, The Lancet, vol.309, issue.8011, p.600, 1977.
DOI : 10.1016/S0140-6736(77)92025-6

M. Berthouze, M. Ayoub, O. Russo, L. Rivail, S. Sicsic et al., receptors in living cells, FEBS Letters, vol.66, issue.14, pp.2973-2980
DOI : 10.1124/mol.104.000497.

J. Bockaert, S. Claeysen, V. Compan, and A. Dumuis, 5-HT4 Receptors, Current Drug Target -CNS & Neurological Disorders, vol.3, issue.1, pp.39-51, 20045.
DOI : 10.2174/1568007043482615
URL : https://hal.archives-ouvertes.fr/hal-01667891

T. Brattelid, A. Kvingedal, K. Krobert, K. Andressen, T. Bach et al., , 2004.

, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i), Cloning Naunyn-Schmiedeberg's Archives of Pharmacology, vol.369, pp.616-628

F. Brouwers, J. Lenders, G. Eisenhofer, and K. Pacak, Reviews in Endocrine and Metabolic Disorders, vol.4, issue.2, pp.121-128, 2003.
DOI : 10.1023/A:1022981801344

D. Cartier, I. Lihrmann, F. Parmentier, C. Bastard, J. Bertherat et al., Receptors in Cisapride-Responsive Adrenocorticotropin-Independent Bilateral Macronodular Adrenal Hyperplasia Causing Cushing???s Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.1, pp.248-254, 2003.
DOI : 10.1210/jc.2002-021107

D. Cartier, S. Jegou, F. Parmentier, I. Lihrmann, E. Louiset et al., -HT4) receptors in adrenocortical aldosterone-producing adenomas, Expression profile of European Journal of Endocrinology, vol.4, issue.153, pp.939-947, 2005.

C. Cavadas, A. Silva, F. Mosimann, M. Cotrim, C. Ribeiro et al., NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.12, pp.5956-5963, 2001.
DOI : 10.1210/jcem.86.12.8091

S. Christopoulos, I. Bourdeau, and A. Lacroix, Clinical and Subclinical ACTH-Independent Macronodular Adrenal Hyperplasia and Aberrant Hormone Receptors, Hormone Research in Paediatrics, vol.38, issue.3, pp.119-131, 2005.
DOI : 10.1210/me.2002-0099

E. Crivellato, N. B. Ribatti, D. Nussdorfer, and G. , , 2006.

, Catecholamine release by chromaffin cells: a lesson from mast cells, General and Comparative Endocrinology, vol.146, pp.69-73

A. Dumuis, M. Sebben, and J. Bockaert, The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.120, issue.4, pp.403-410, 1989.
DOI : 10.1007/BF00167041

G. Eisenhofer, G. Rivers, A. Rosas, Z. Quezado, W. &. Manger et al., Adverse Drug Reactions in Patients with Phaeochromocytoma, Drug Safety, vol.140, issue.11, pp.1031-1062, 2007.
DOI : 10.7326/0003-4819-140-10-200405180-00033

L. Fink, W. Seeger, L. Ermert, J. Hänze, U. Stahl et al., Real-time quantitative RT???PCR after laser-assisted cell picking, Nature Medicine, vol.12, issue.11, pp.1329-1333, 1998.
DOI : 10.1016/0076-6879(93)25039-5

R. Fraser, Dopamine regulation of aldosterone secretion: an open question?, Journal of Endocrinology, vol.112, issue.2, pp.179-181, 1987.
DOI : 10.1677/joe.0.1120179

A. Gross, Y. Goh, R. Addison, and G. Shenfield, Influence of grapefruit juice on cisapride pharmacokinetics, Clinical Pharmacology & Therapeutics, vol.65, issue.4, pp.395-401, 1999.
DOI : 10.1016/S0009-9236(99)70133-5

C. Grossman, G. Kilpatrick, and K. Bunce, Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain, British Journal of Pharmacology, vol.100, issue.3, pp.618-624, 1993.
DOI : 10.1111/j.1476-5381.1990.tb14073.x

J. Guillemot, Y. Anouar, M. Montero-hadjadje, E. Grouzmann, L. Grumolato et al., Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma, International Journal of Cancer, vol.24, issue.8, pp.2003-2012, 2006.
DOI : 10.1001/jama.288.3.314
URL : https://hal.archives-ouvertes.fr/hal-01706431

R. Harrington, C. Hamilton, R. Brogden, J. Linkewich, J. Romankiewicz et al., Metoclopramide, Drugs, vol.25, issue.5, pp.451-494, 1983.
DOI : 10.2165/00003495-198325050-00002

T. Hsu, C. Lee, and C. Kuo, Diagnostic use of metoclopramide in hypertension caused by pheochromocytoma, International Journal of Cardiology, vol.42, issue.1, pp.79-86, 1993.
DOI : 10.1016/0167-5273(93)90105-P

R. Joannides, N. Moore, M. Iacob, P. Compagnon, A. Bacri et al., Divergent effects of verapamil and amlodipine at rest and during exercise, Journal of Hypertension, vol.16, pp.25-29, 1998.

H. Keiser and . Jameson, Pheochromocytoma and related tumors, In Endocrinology Eds LJ DeGroot &, vol.3, issue.4, pp.1862-1883, 2001.

H. Lamparczyk, A. Chmielewska, L. Konieczna, A. Plenis, and P. Zarzycki, RP-HPLC method with electrochemical detection for the determination of metoclopramide in serum and its use in pharmacokinetic studies, Biomedical Chromatography, vol.33, issue.8, pp.513-517, 2001.
DOI : 10.1002/jps.2600681015

H. Lefebvre, V. Contesse, C. Delarue, C. Soubrane, A. Legrand et al., of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex, vivo and in vitro studies, pp.1662-1666, 1993.

N. Van-lelyveld, T. Linde, J. Schipper, M. Samsom, and M. , receptors in the human stomach and duodenum, Neurogastroenterology & Motility, vol.275, issue.4, pp.342-348, 2007.
DOI : 10.1016/j.amjsurg.2005.07.012

M. Leow and K. Loh, Accidental provocation of phaeochromocytoma: the forgotten hazard of metoclopramide?, Singapore Medical Journal, vol.46, pp.557-560, 2005.

M. Mannelli, C. Pupilli, R. Lanzillotti, L. Ianni, F. Bellini et al., Role for Endogenous Dopamine in Modulating Sympathetic-Adrenal Activity in Humans, Hypertension Research, vol.18, issue.SupplementI, pp.79-86, 1995.
DOI : 10.1291/hypres.18.SupplementI_S79
URL : https://www.jstage.jst.go.jp/article/hypres1992/18/SupplementI/18_SupplementI_S79/_pdf

P. Maxwell, C. Buckley, J. Gleadle, and P. Mason, Nasty shock after an anti???emetic, Nephrology Dialysis Transplantation, vol.16, issue.5, pp.1069-1072, 2001.
DOI : 10.1093/ndt/16.5.1069
URL : https://academic.oup.com/ndt/article-pdf/16/5/1069/5117084/161069.pdf

, Molitch ME 1992 Pathologic hyperprolactinemia, pp.877-901

M. Montero-hadjadje, H. Vaudry, V. Turquier, J. Leprince, D. Rego et al., Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands, Cell and Tissue Research, vol.310, issue.2, pp.223-236, 2002.
DOI : 10.1007/s00441-002-0625-9
URL : https://hal.archives-ouvertes.fr/hal-01973127

G. Norbiato, M. Bevilacqua, U. Raggi, P. Micossi, and . Moroni, METOCLOPRAMIDE INCREASES PLASMA ALDOSTERGNE CONCENTRATION IN MAN, The Journal of Clinical Endocrinology & Metabolism, vol.45, issue.6, pp.1313-1316, 1977.
DOI : 10.1210/jcem-45-6-1313

P. Plouin and M. , HYPERTENSIVE CRISIS IN PATIENT WITH PH??OCHROMOCYTOMA GIVEN METOCLOPRAMIDE, The Lancet, vol.308, issue.7999, pp.1357-1358, 1976.
DOI : 10.1016/S0140-6736(76)92008-0

C. Rizzi, J. Mierau, and . Ladinsky, Regulation of Plasma Aldosterone Levels by Metoclopramide: a Reappraisal of its Mechanism from Dopaminergic Antagonism to Serotonergic Agonism, Neuropharmacology, vol.36, issue.6, pp.763-768, 1997.
DOI : 10.1016/S0028-3908(97)00025-7

, Sever PS 1977 Hypertensive crisis in patients with phaeochromocytoma given metoclopramide, Lancet, vol.1, p.703

K. Wu, Y. Chen, T. Chu, S. Chueh, M. Wu et al., Expression and Localization of Human Dopamine D2 and D4 Receptor mRNA in the Adrenal Gland, Aldosterone-Producing Adenoma, and Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.9, pp.4460-4467, 2001.
DOI : 10.1210/jcem.86.9.7859

L. Yon, J. Guillemot, M. Montero-hadjadje, L. Grumolato, J. Leprince et al., Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-2585, 2003.
DOI : 10.1210/jc.2002-021748
URL : https://hal.archives-ouvertes.fr/hal-01706414